NEW YORK —
The Peterson Health Technology Institute (PHTI), the first independent evaluator of digital health solutions in the U.S., announced today the appointment of seven nationally-recognized industry leaders to serve as inaugural members on its Advisory Board.
The Advisory Board members bring deep expertise and diverse perspectives from across the healthcare industry to support PHTI’s work developing rigorous, evidence-based analysis of the clinical benefits and economic impact of digital health solutions.
“I am thrilled to welcome these respected experts, who will enhance and elevate our work to identify and drive adoption of high-value health technologies,” said Caroline Pearson, executive director of PHTI. “Digital health technologies hold enormous potential to transform healthcare, but we’re just beginning to understand what works. This talented Advisory Board brings together perspectives from across the healthcare stakeholder ecosystem, including payers, providers, policymakers, consumers, investors, and entrepreneurs, and will help advance PHTI’s work to accelerate the adoption of high-value technology in healthcare.”
PHTI Advisory Board members include leaders spanning academia, healthcare innovation, digital technology and economics:
- Melinda Buntin, Ph.D., Bloomberg Distinguished Professor of Health Policy and Economics, Johns Hopkins University
- Thomas Insel, M.D., Co-Founder and Executive Chair, Vanna Health; former Director, National Institute of Mental Health (NIMH)
- Margaret McKenna, Advisory Partner, Andreessen Horowitz; former co-Chief Technology Officer, Devoted Health
- Anaeze Offodile II, M.D., MPH, Executive Vice-President and Chief Strategy Officer, Memorial Sloan Kettering Cancer Center
- William Shrank, M.D., Venture Partner,Andreessen Horowitz; former Chief Medical Officer, Humana
- Ariel Stern, Ph.D., Incoming Digital Health Chair and Humboldt Professor of Digital Engineering, University of Potsdam; Poronui Associate Professor of Business Administration, Harvard Business School
- Charlotte Yeh, M.D., Chief Medical Officer, AARP Services, Inc.
While emerging health technologies have rapidly expanded in recent years, many are not subject to U.S. Food and Drug Administration review and lack high-quality clinical evidence. Starting early next year, PHTI will release freely-available assessment reports evaluating digital health tools in popular clinical areas. Consistent with PHTI’s commitment to independent evaluations, Advisory Board members will not select technology topics or products for assessment, nor will they have a role in evidence reviews, the assessment process, or approval of final reports.
About the Peterson Health Technology Institute
The Peterson Health Technology Institute (PHTI) provides independent evaluations of innovative healthcare technologies to improve health and lower costs. Through its rigorous, evidence-based research, PHTI analyzes the clinical benefits and economic impact of digital health solutions, as well as their effects on health equity, privacy, and security. These evaluations inform decisions for providers, patients, payers, and investors, accelerating the adoption of high-value technology in healthcare. PHTI was founded in 2023 by the Peterson Center on Healthcare. For more information, please visit PHTI.com.